Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|May 1, 2019

BioPharm International

  • BioPharm International-05-01-2019
  • Volume 32
  • Issue 5

Multichannel Pipettes for 384-Well Plates

Eppendorf’s 16- and 24-channel pipettes can handle entire columns and rows of a 384-well plate in one step.

Eppendorf’s 16- and 24-channel pipettes can handle entire columns and rows of a 384-well plate in one step. An entire plate can be managed manually within a minute, and up to 24 reactions may be started and stopped simultaneously, according to the company.

The pipettes come with epT.I.P.S. 384 and ep Dualfilter T.I.P.S. 384 systems for improved security and comfort. The SOFTattach technology uses elastic forming grooves that contribute to a precise tip fit and seal. The company states that tip attachment forces are reduced by up to an additional 40% per tip. The system’s fine tip shape and coaxiality makes maneuvering samples into the tiny wells of a 384-well plate secure. The pipettes are available as both mechanical and electronic.

Eppendorf


Related to this article

The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide
FDA grants RMAT and Fast Track designations to AbelZeta’s CD20/CD19 bispecific CAR-T prizlon-cel in relapsed or refractory large B-cell lymphoma, Larimar Therapeutics completes a BLA seeking accelerated approval of nomlabofusp for Friedreich’s ataxia, and Merck’s GLP-1/glucagon receptor agonist efinopegdutide meets its primary endpoint in a phase 2b MASH trial.